Dynamic, Large-Scale Profiling of Transcription Factor Activity from Live Cells in 3D Culture

Background Extracellular activation of signal transduction pathways and their downstream target transcription factors (TFs) are critical regulators of cellular processes and tissue development. The intracellular signaling network is complex, and techniques that quantify the activities of numerous pathways and connect their activities to the resulting phenotype would identify the signals and mechanisms regulating tissue development. The ability to investigate tissue development should capture the dynamic pathway activity and requires an environment that supports cellular organization into structures that mimic in vivo phenotypes. Taken together, our objective was to develop cellular arrays for dynamic, large-scale quantification of TF activity as cells organized into spherical structures within 3D culture. Methodology/Principal Findings TF-specific and normalization reporter constructs were delivered in parallel to a cellular array containing a well-established breast cancer cell line cultured in Matrigel. Bioluminescence imaging provided a rapid, non-invasive, and sensitive method to quantify luciferase levels, and was applied repeatedly on each sample to monitor dynamic activity. Arrays measuring 28 TFs identified up to 19 active, with 13 factors changing significantly over time. Stimulation of cells with β-estradiol or activin A resulted in differential TF activity profiles evolving from initial stimulation of the ligand. Many TFs changed as expected based on previous reports, yet arrays were able to replicate these results in a single experiment. Additionally, arrays identified TFs that had not previously been linked with activin A. Conclusions/Significance This system provides a method for large-scale, non-invasive, and dynamic quantification of signaling pathway activity as cells organize into structures. The arrays may find utility for investigating mechanisms regulating normal and abnormal tissue growth, biomaterial design, or as a platform for screening therapeutics.

[1]  J. Mester,et al.  Estrogen induction of the cyclin D1 promoter: involvement of a cAMP response-like element. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[2]  David J. Mooney,et al.  Inspiration and application in the evolution of biomaterials , 2009, Nature.

[3]  R. Iyengar,et al.  Signaling Networks The Origins of Cellular Multitasking , 2000, Cell.

[4]  D T Denhardt,et al.  Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: the potential for multiplex signalling. , 1996, The Biochemical journal.

[5]  S. Safe,et al.  Estrogen regulation of c-fos gene expression through phosphatidylinositol-3-kinase-dependent activation of serum response factor in MCF-7 breast cancer cells. , 2002, Biochemical and biophysical research communications.

[6]  V. Jordan,et al.  Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit? , 2009, Breast Cancer Research.

[7]  Goberdhan P Dimri,et al.  Modeling breast cancer-associated c-Src and EGFR overexpression in human MECs: c-Src and EGFR cooperatively promote aberrant three-dimensional acinar structure and invasive behavior. , 2007, Cancer research.

[8]  E. Ariazi,et al.  Bioluminescence imaging for assessment and normalization in transfected cell arrays , 2007, Biotechnology and bioengineering.

[9]  Cynthia A. Reinhart-King,et al.  Tensional homeostasis and the malignant phenotype. , 2005, Cancer cell.

[10]  Christoph W. Turck,et al.  Nuclear Export of NF-ATc Enhanced by Glycogen Synthase Kinase-3 , 1997, Science.

[11]  C. Marshall,et al.  Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation , 1995, Cell.

[12]  Xiao-Fan Wang,et al.  Activin induces hepatocyte cell growth arrest through induction of the cyclin-dependent kinase inhibitor p15INK4B and Sp1. , 2004, Cellular signalling.

[13]  A. Hoffmann,et al.  The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. , 2002, Science.

[14]  A. Philips,et al.  Estradiol increases and anti-estrogens antagonize the growth factor-induced activator protein-1 activity in MCF7 breast cancer cells without affecting c-fos and c-jun synthesis. , 1993, The Journal of biological chemistry.

[15]  C. Harris,et al.  p53 tumor suppressor gene: from the basic research laboratory to the clinic--an abridged historical perspective. , 1996, Carcinogenesis.

[16]  Douglas A. Lauffenburger,et al.  Common effector processing mediates cell-specific responses to stimuli , 2007, Nature.

[17]  G. Courtois,et al.  Mutations in the NF-kappaB signaling pathway: implications for human disease. , 2006, Oncogene.

[18]  Ali H. Brivanlou,et al.  Signaling Pathways in Cancer and Embryonic Stem Cells , 2007, Stem Cell Reviews.

[19]  L. Boxer,et al.  The expression of p53 tumor suppressor gene in breast cancer cells is down-regulated by cytokine oncostatin M. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[20]  Genee Y. Lee,et al.  The morphologies of breast cancer cell lines in three‐dimensional assays correlate with their profiles of gene expression , 2007, Molecular oncology.

[21]  Howard Y. Chang,et al.  Modeling inducible human tissue neoplasia identifies an extracellular matrix interaction network involved in cancer progression. , 2009, Cancer cell.

[22]  Yasmin Sitabkhan,et al.  Estradiol-Induced Regression in T47D:A18/PKCα Tumors Requires the Estrogen Receptor and Interaction with the Extracellular Matrix , 2009, Molecular Cancer Research.

[23]  Radhika Desai,et al.  ROCK-generated contractility regulates breast epithelial cell differentiation in response to the physical properties of a three-dimensional collagen matrix , 2003, The Journal of cell biology.

[24]  Sergei Romanov,et al.  Homogeneous reporter system enables quantitative functional assessment of multiple transcription factors , 2008, Nature Methods.

[25]  U. Bhalla,et al.  Emergent properties of networks of biological signaling pathways. , 1999, Science.

[26]  Ingrid Lönnstedt.  Replicated microarray data , 2001 .

[27]  A. Hoffmann,et al.  The I (cid:1) B –NF-(cid:1) B Signaling Module: Temporal Control and Selective Gene Activation , 2022 .

[28]  Chao Cheng,et al.  BMC Genomics BioMed Central Methodology article , 2008 .

[29]  D. Schaffer,et al.  Kinetic analysis and modeling of firefly luciferase as a quantitative reporter gene in live mammalian cells , 2004, Biotechnology and bioengineering.

[30]  B. Kholodenko.  Cell-signalling dynamics in time and space , 2006, Nature Reviews Molecular Cell Biology.

[31]  Sophie Lelièvre,et al.  beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. , 2002, Cancer cell.

[32]  D. Louis,et al.  Deregulation of a STAT3–Interleukin 8 Signaling Pathway Promotes Human Glioblastoma Cell Proliferation and Invasiveness , 2008, The Journal of Neuroscience.

[33]  B S Weir,et al.  Truncated product method for combining P‐values , 2002, Genetic epidemiology.

[34]  S. Dedieu,et al.  Retinoids interfere with the AP1 signalling pathway in human breast cancer cells. , 2006, Cellular signalling.

[35]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[36]  J. Lachuer,et al.  Overexpression of Transcription Factor Sp1 Leads to Gene Expression Perturbations and Cell Cycle Inhibition , 2009, PloS one.

[37]  C. Heldin,et al.  Signaling networks guiding epithelial–mesenchymal transitions during embryogenesis and cancer progression , 2007, Cancer science.

[38]  Mehmet Toner,et al.  A high-throughput microfluidic real-time gene expression living cell array. , 2007, Lab on a chip.

[39]  Gordon K. Smyth,et al.  limma: Linear Models for Microarray Data , 2005 .

[40]  D. Lauffenburger,et al.  Quantitative analysis of synthetic gene delivery vector design properties. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[41]  V. Rotter,et al.  p53 Plays a Role in Mesenchymal Differentiation Programs, in a Cell Fate Dependent Manner , 2008, PloS one.

[42]  H. Kleinman,et al.  Matrigel: basement membrane matrix with biological activity. , 2005, Seminars in cancer biology.

[43]  P. Brown,et al.  The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors , 2008, Oncogene.

[44]  Michael Karin,et al.  NF-kappaB: linking inflammation and immunity to cancer development and progression. , 2005, Nature reviews. Immunology.

[45]  J. C. Pratt,et al.  The Small GTP-Binding Protein Rho Potentiates AP-1 Transcription in T Cells , 1998, Molecular and Cellular Biology.

[46]  E. J. Lee,et al.  Activin A mediates growth inhibition and cell cycle arrest through Smads in human breast cancer cells. , 2005, Cancer research.

[47]  S. Souchelnytskyi.  Proteomics in Studies of Signal Transduction in Epithelial Cells , 2002, Journal of Mammary Gland Biology and Neoplasia.

[48]  M. Bissell,et al.  Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[49]  C. Streuli,et al.  Adhesion-Mediated Signaling in the Regulation of Mammary Epithelial Cell Survival , 1999, Journal of Mammary Gland Biology and Neoplasia.

[50]  Leslie M. Shaw,et al.  The role of NFAT transcription factors in integrin-mediated carcinoma invasion , 2002, Nature Cell Biology.

[51]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[52]  Chawnshang Chang,et al.  An estrogen receptor positive MCF-7 clone that is resistant to antiestrogens and estradiol , 1992, Molecular and Cellular Endocrinology.

[53]  Lonnie D Shea,et al.  Non-viral vector delivery from PEG-hyaluronic acid hydrogels. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[54]  J. Darnell.  Transcription factors as targets for cancer therapy , 2002, Nature Reviews Cancer.

[55]  S. Inoue,et al.  Estrogen receptors and their downstream targets in cancer. , 2004, Archives of histology and cytology.

[56]  Shelly R Peyton,et al.  The effects of matrix stiffness and RhoA on the phenotypic plasticity of smooth muscle cells in a 3-D biosynthetic hydrogel system. , 2008, Biomaterials.

[57]  C. Marshall,et al.  Rho GTPases in human cancer: an unresolved link to upstream and downstream transcriptional regulation. , 2004, Biochimica et biophysica acta.

[58]  Rey-Huei Chen,et al.  Molecular interpretation of ERK signal duration by immediate early gene products , 2002, Nature Cell Biology.

[59]  Jayanta Debnath,et al.  Modelling glandular epithelial cancers in three-dimensional cultures , 2005, Nature Reviews Cancer.

[60]  S. Haslam,et al.  Laminin inhibits estrogen action in human breast cancer cells. , 2000, Endocrinology.

[61]  G. Semenza.  Targeting HIF-1 for cancer therapy , 2003, Nature Reviews Cancer.

[62]  P. Bontempo,et al.  Estradiol induces functional inactivation of p53 by intracellular redistribution. , 2000, Cancer research.

[63]  Gordon K Smyth,et al.  Statistical Applications in Genetics and Molecular Biology Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2011 .

[64]  Seong-Jin Kim,et al.  Negative regulation of Activin/Nodal signaling by SRF during Xenopus gastrulation , 2007, Development.

[65]  Serge Lemay,et al.  The p38 MAPK Pathway Is Required for Cell Growth Inhibition of Human Breast Cancer Cells in Response to Activin* , 2001, The Journal of Biological Chemistry.

[66]  Michael F. Olson,et al.  RAS and RHO GTPases in G1-phase cell-cycle regulation , 2004, Nature Reviews Molecular Cell Biology.